NOVT NOVANTA INC
FY2025 10-K
Filed: Feb 23, 2026
Information Technology
Miscellaneous Electrical Machinery, Equipment & SuppliesSEC EDGAR NOVANTA INC (NOVT) filed its fiscal year 2025 10-K annual report with the SEC on Feb 23, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business: Supplier of proprietary technology solutions for medical, life science, and advanced industrial OEMs focused on precision and performance
- • New emphasis on RFID solutions through acquisition of Keonn Technologies for €64.8M ($71.0M), included in Medical Solutions segment
Risk Factors
- • Regulatory/legal risk: Restrictions on dividends and asset transfers from foreign subsidiaries under local laws impacting funding for parent operations
- • Geopolitical/macro risk: $67.6M cash and $74M debt held by non-North American subsidiaries, limiting capital repatriation flexibility
Financial SummaryXBRL
Revenue
$981M
Net Income
$54M
Gross Margin
44.4%
Operating Margin
9.6%
Net Margin
5.5%
ROE
4.1%
Total Assets
$1.8B
EPS (Diluted)
$1.47
Operating Cash Flow
$64M
Source: XBRL data from NOVANTA INC FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on NOVANTA INC
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.